애완동물용 재택 진단 검사 시장 : 동물 유형별, 용도별, 샘플 유형별, 유통 채널별, 지역별, 기회, 예측(2018-2032년)

Global pet at-home diagnostic test market is projected to witness a CAGR of 6.23% during the forecast period 2025-2032, growing from USD 100.14 million in 2024 to USD 162.40 million in 2032. The pet at-home diagnostic test market is expanding rapidly because more people own pets, while people become conscious about animal health, and they select preventive veterinary services. Through these diagnostic kits, pet owners can test biological samples at home by collecting blood, urine, or feces samples, thereby minimizing animal stress while reducing the need for clinical visits.

The market expanded through biotechnology developments and telehealth implementation, and user-focused designs, which made home testing more dependable and convenient. The largest market share belongs to North America due to its substantial financial resources for pet health and an established veterinary network, along with its tendency to quickly adopt diagnostic technologies. Europe maintains the second position, but the Asia-Pacific region shows the most rapid market development due to urban growth, increasing disposable income, and rising pet care education. The market demonstrates market dominance through blood-based diagnostics, as these tests can detect diabetes, infections, and organ dysfunction. Fecal and urine-based tests are becoming more popular because they use non-invasive methods and customers can purchase them through retail stores and online platforms. The market is expected to demonstrate strong growth potential over the next decade, driven by the continued expansion of tele-veterinary platforms, increased focus on pet wellness, and technological advancements in at-home diagnostic solutions.

Additionally, to support the growth of the at-home diagnostic test market, key players are engaging in strategic mergers and acquisitions. For instance, in August 2024, Bansk Group, a private equity firm, acquired PetIQ through a deal worth about USD 1.5 billion, which granted them control of PetIQ's broad selection of pet health products, including diagnostic tests. Through this acquisition, businesses can enhance their product lines, access new technological solutions, and strengthen their market position, ultimately driving faster growth across the pet diagnostics market.

Growing Pet Ownership Drives Global Pet At-home Diagnostic Test Market Demand

The rise in pet ownership globally has significantly influenced the demand for home-based testing products for animals. The growing number of people who have pet relationships has led to changes in care methods, as owners now provide their animals with similar levels of attention to that they dedicate to family members. People now view pets differently, leading to a better understanding of their health needs and overall well-being. People who own pets now take more responsibility to observe their animals' health conditions by using simple testing options that avoid veterinary visits. The testing methods provided by home diagnostic kits serve pet owners who need easy procedures to minimize stress during veterinary visits, especially for nervous or senior animals. These home diagnostic kits enable pet owners to identify health issues early, leading to prompt treatment and improved recovery outcomes. The specialized pet healthcare market segment continues to grow because pet owners choose prevention and wellness through accessible at-home diagnostic solutions.

For instance, in July 2024, Researchers from Chulalongkorn University developed an easy, fast, and accurate Cat Urine Test Kit to help pet owners screen for early signs of kidney disease, gallstones, and cystitis in cats. The kit detects hematuria (blood in urine) and offers a pain-free, home-based alternative to invasive veterinary procedures. Such innovation helps pet owners to examine a pet diagnostic test at home.

Telemedicine and Mobile Health Trends Support Market Growth

The expanding use of telemedicine and mobile health solutions drives the fast growth of the pet at-home diagnostic test market. Virtual veterinary care, facilitated by digital transformation, has built trust among pet owners, enabling them to manage their pets' health remotely through remote monitoring and virtual consultations. The rise in popularity of at-home diagnostic kits stems from their ability to remove clinical visit requirements while providing sample gathering and result transmission capabilities. Through the current trend, pet owners can perform home diagnostic tests and access veterinary assessments through mobile applications or web platforms to evaluate infections, track wellness and monitor chronic diseases. The solution offers improved convenience, reduced financial costs, and decreased physical strain associated with multiple clinic visits. These solutions prove valuable to pets that experience anxiety or face mobility challenges, as well as to those residing in rural locations where veterinary services are scarce. Users receive assistance from telehealth platforms during the testing process, allowing them to transmit results instantly for faster diagnosis and informed medical decisions. The ongoing development of mobile health technology will enhance its integration with at-home diagnostics, thereby driving increased demand and improved healthcare outcomes for pets.

For instance, in May 2025, TelmyVet and PetPace announced a Quality-of-Life Consultation, a new virtual care service designed to help pets and their families during end-of-life stages. The new service offers compassionate, data-driven end-of-life care through TelmyVet's advanced telemedicine platform, in conjunction with PetPace's award-winning wearable AI and machine learning dog health monitor.

Blood Sample-Based Test Holds Largest Global Pet At-home Diagnostic Test Market Share

Blood sample-based tests hold the largest market share in the pet at-home diagnostic test market due to their ability to deliver broad diagnostic capabilities with high accuracy. Blood serves as a vital sample that provides essential health data for identifying various diseases, including diabetes, as well as kidney and liver disorders, infections, and hormonal problems. Tests serve as crucial tools for both identifying chronic diseases early and tracking their progression, as these conditions are on the rise among older pets. Home blood testing kits, created with modern technology, provide improved usability that enables pet owners to collect small blood samples safely using lancets or capillary tubes. Users can rely on these diagnostic kits because they provide detailed instructions, along with digital support tools, that help users understand the tests and boost their confidence in test usage. Modern diagnostic technology has developed compact testing equipment and smartphone-based diagnostic tools that bring blood testing capabilities directly to home environments. The veterinary community relies on blood test outcomes because these results provide dependable medical information, enabling doctors to deliver precise remote care. Blood-based at-home diagnostic tests maintain their market dominance because pet owners are increasingly choosing preventive care options, thereby driving higher demand for these tests.

For instance, Zoetis Inc. is poised to lead the animal health industry worldwide with the launch of the Vetscan OptiCell hematology analyzer in September 2024, to perform advanced Complete Blood Count (CBC) analysis using AI technology in a cartridge-based design.

North America Dominates the Pet At-home Diagnostic Test Market Size

The North American pet at-home diagnostic test market is the leading market due to the strong pet ownership culture and advanced veterinary healthcare infrastructure. The pet owners of this area actively care for their animals by using convenient preventive care methods, which have gained popularity. Advanced technological diagnostic kits, a strong e-commerce system, and extensive telemedicine availability have accelerated the market growth. Veterinary professionals in North America are increasingly opting for at-home testing as an effective way to detect diseases early, thereby monitoring pets, which is leading to growing acceptance among pet owners. The presence of essential industry leaders, along with ongoing research funding, drives product innovation and availability throughout the region. Digital health tools combined with strong purchasing power and high awareness have made North America the largest market for pet at-home diagnostics, while maintaining consistent market growth for the future.

Additionally, the growing awareness of pet health among pet owners, along with the investments they are making, is also increasing the demand for at-home diagnostic kits. For instance, according to the Frobe Advisor report, as of January 2025, there were 5.36 million insured pets in the U.S., with about 80% being dogs and 20% being cats. Such investment in pet health supports growth in the diagnostic test market for this region.

Impact of U.S. Tariffs on the Global Pet At-home Diagnostic Test Market

U.S. tariffs significantly impact the at-home pet diagnostic test market by driving up the import prices of essential testing product components. The higher tariffs on foreign-produced raw materials and testing kits increase manufacturing expenses, which generally causes businesses to raise their prices toward their end customers. The increased prices may decrease consumer interest in affordable pet diagnostic tools, potentially slowing market expansion. Tariffs create supply chain disruptions, resulting in product delays and slower innovation. The temporary advantage for domestic producers comes at the cost of market development because of price increases and unpredictable supply availability. Companies face higher fees, which drive them to develop local solutions and explore different sourcing options, thereby changing market competition. The combination of U.S. tariffs makes the market environment complex by affecting product costs, supply chain reliability, and innovation capacity, which determine the future path of pet at-home diagnostic tests.

Key Players Landscape and Outlook

At-home diagnostic tests for pets operate within a highly competitive market because businesses deliver innovative solutions through digital platforms that meet the expanding needs of customers. Leading companies dedicate their resources to research and development activities that produce precise and simple diagnostic kits, enabling early diagnosis alongside preventive health management. Companies dedicate resources to building strategic alliances between telehealth services and mobile health platforms for improved user access and engagement. Companies pursue growth through product portfolio expansion, distribution channel enhancement and innovative technology integration for real-time diagnostics. The market outlook remains positive because rising pet healthcare awareness, along with digital transformation, generates new business prospects for providers offering accessible, connected, and cost-effective diagnostic solutions.

In August 2024, Affordable Pet Labs introduced a superior fecal examination system specifically designed for cats, which delivers enhanced parasite detection results at home, thereby improving pet healthcare services. The new testing approach enables owners to identify parasites at an early stage, resulting in superior treatment outcomes for their cats and enhanced veterinary care.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Animal Type
    • 5.2.1.1. Dogs
    • 5.2.1.2. Cats
    • 5.2.1.3. Others
  • 5.2.2. By Application
    • 5.2.2.1. Parasitic Diseases
    • 5.2.2.2. Infectious Diseases
    • 5.2.2.3. Fertility Testing
    • 5.2.2.4. Chronic and Metabolic Diseases
    • 5.2.2.5. Genetic Conditions and Allergies
    • 5.2.2.6. Other
  • 5.2.3. By Sample Type
    • 5.2.3.1. Blood
    • 5.2.3.2. Urine
    • 5.2.3.3. Fecal
    • 5.2.3.4. Others
  • 5.2.4. By Distribution Channel
    • 5.2.4.1. Veterinary Hospitals/Clinics
    • 5.2.4.2. E-commerce
    • 5.2.4.3. Retail Pharmacies
  • 5.2.5. By Region
    • 5.2.5.1. North America
    • 5.2.5.2. Europe
    • 5.2.5.3. Asia-Pacific
    • 5.2.5.4. South America
    • 5.2.5.5. Middle East and Africa
  • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Animal Type
  • 5.3.2. By Application
  • 5.3.3. By Sample Type
  • 5.3.4. By Distribution Channel
  • 5.3.5. By Region

6. North America Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Animal Type
    • 6.2.1.1. Dogs
    • 6.2.1.2. Cats
    • 6.2.1.3. Others
  • 6.2.2. By Application
    • 6.2.2.1. Parasitic Diseases
    • 6.2.2.2. Infectious Diseases
    • 6.2.2.3. Fertility Testing
    • 6.2.2.4. Chronic and Metabolic Diseases
    • 6.2.2.5. Genetic Conditions and Allergies
    • 6.2.2.6. Other
  • 6.2.3. By Sample Type
    • 6.2.3.1. Blood
    • 6.2.3.2. Urine
    • 6.2.3.3. Fecal
    • 6.2.3.4. Others
  • 6.2.4. By Distribution Channel
    • 6.2.4.1. Veterinary Hospitals/Clinics
    • 6.2.4.2. E-commerce
    • 6.2.4.3. Retail Pharmacies
  • 6.2.5. By Country Share
    • 6.2.5.1. United States
    • 6.2.5.2. Canada
    • 6.2.5.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Pet At-home Diagnostic Tests Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.1.1. Dogs
        • 6.3.1.2.1.2. Cats
        • 6.3.1.2.1.3. Others
      • 6.3.1.2.2. By Application
        • 6.3.1.2.2.1. Parasitic Diseases
        • 6.3.1.2.2.2. Infectious Diseases
        • 6.3.1.2.2.3. Fertility Testing
        • 6.3.1.2.2.4. Chronic and Metabolic Diseases
        • 6.3.1.2.2.5. Genetic Conditions and Allergies
        • 6.3.1.2.2.6. Other
      • 6.3.1.2.3. By Sample Type
        • 6.3.1.2.3.1. Blood
        • 6.3.1.2.3.2. Urine
        • 6.3.1.2.3.3. Fecal
        • 6.3.1.2.3.4. Others
      • 6.3.1.2.4. By Distribution Channel
        • 6.3.1.2.4.1. Veterinary Hospitals/Clinics
        • 6.3.1.2.4.2. E-commerce
        • 6.3.1.2.4.3. Retail Pharmacies
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Pet At-home Diagnostic Tests Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Affordable Pet Labs
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 20.3.2. Ring Biotechnology Co Ltd
  • 20.3.3. Forte Healthcare Private Limited
  • 20.3.4. Guangzhou Wondfo Biotech Co., Ltd
  • 20.3.5. Vitrosens Biyoteknoloji Ltd. Sti
  • 20.3.6. HANGZHOU EVEGEN BIOTECH CO., LTD.
  • 20.3.7. BioMetallics Inc.
  • 20.3.8. Touch Biotechnology Pty Ltd.
  • 20.3.9. FLASHTEST Technology Co. Ltd.
  • 20.3.10. Animal Microbiome Analytics, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendation

22. About Us and Disclaimer